
Tulane University Human Research Protections Office Standard Operating Procedures - Full Version
1. Human Research Protection Program
3.8 Criteria for IRB Approval of Research
3.9 Additional Considerations During Review
3.10 Compliance with Applicable Laws and Regulations
3.12 Study Suspension, Termination and Investigator Hold
3.14 Amendment of an Approved Protocol
3.16 Notice to PI of IRB Actions
3.17 Appeal of IRB Decision to Disapprove
3.18 National Cancer Institute's Central IRB
4.12 Records for FDA-Regulated Studies
5. Obtaining Informed Consent from Research Subjects
5.5 Basic Elements of Informed Consent Process
5.6 Additional Elements of Informed Consent to be Applied, as Appropriate
5.7 Documentation of Informed Consent
5.8 Special Consent Circumstances
5.10 Consenting in American Sign Language
5.13 Subject Withdrawal or Termination
5.14 Waiver of Informed Consent
5.15 Waiver of Documentation of Informed Consent
6. Vulnerable Subjects in Research
6.6 Research Involving Pregnant Women or Fetuses
6.7 Research Involving Neonates
6.8 Research Involving Prisoners
6.9 Research Involving Children
7.8 Investigational Devices in Research
8. Unanticipated Problems Involving Risks to Subjects or Others
9. Protocol Violations, Deviations, and Exceptions
10. Complaints and Non-Compliance
11. Reporting to Regulatory Agencies and Institutional Officials
12. Investigator Responsibilities
14. Conflicts of Interest in Research
16. Health Insurance Portability and Accountability Act (HIPAA)
17. Collaborative Resarch and Off-Site Research
18.1 Certificate of Confidentiality
18.2 Mandatory Reporting of Abuse and Neglect
18.6 Public Registration of Clinical Trials
18.8 Research Involving Coded private Information or Biological Specimens
Institutional Review Board, New Orleans, LA 70112 504-988-2665 irbmain@tulane.edu